UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 140

Sortiert nach

Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial

Diabetes, obesity & metabolism, 2009-06, Vol.11 (6), p.611-622

2009

Volltextzugriff (PDF)

Efficacy of birinapant in combination with carboplatin in targeting platinum‑resistant epithelial ovarian cancers

International journal of oncology, 2022-03, Vol.60 (3), p.1, Article 35

2022

Volltextzugriff (PDF)

Durability of glycaemic control with dapagliflozin, an SGLT2 inhibitor, compared with saxagliptin, a DPP4 inhibitor, in patients with inadequately controlled type 2 diabetes

Diabetes, obesity & metabolism, 2019-11, Vol.21 (11), p.2564-2569

2019

Volltextzugriff (PDF)

Prostate-specific membrane antigen-targeted endoradiotherapy in metastatic prostate cancer

Current opinion in urology, 2020-01, Vol.30 (1), p.98

2020

Volltextzugriff (PDF)

Dipeptidyl peptidase-4 inhibitors: pharmacokinetics, efficacy, tolerability and safety in renal impairment

Diabetes, obesity & metabolism, 2014-10, Vol.16 (10), p.891-899

Davis, T. M. E.

2014

Volltextzugriff (PDF)

Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin

Archives of Endocrinology and Metabolism, 2018-08, Vol.62 (4), p.424-430

2018

Volltextzugriff (PDF)

Effect of VX‑765 on the transcriptome profile of mice spinal cords with acute injury

Molecular medicine reports, 2020-07, Vol.22 (1), p.33-42

2020

Volltextzugriff (PDF)

The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphoma

Oncotarget, 2016-10, Vol.7 (43), p.69625-69637

2016

Volltextzugriff (PDF)

Inhibition of ileal bile acid transporter: An emerging therapeutic strategy for chronic idiopathic constipation

World journal of gastroenterology : WJG, 2015-06, Vol.21 (24), p.7436-7442

2015

Volltextzugriff (PDF)

Baseline differences in the SAVOR trial

Diabetes, obesity & metabolism, 2015-12, Vol.17 (12), p.1202-1202

2015

Volltextzugriff (PDF)

Saxagliptin and sitagliptin in adult patients with type 2 diabetes: a systematic review and meta-analysis

Diabetes, obesity & metabolism, 2012-06, Vol.14 (6), p.481-492

2012

Volltextzugriff (PDF)

Saxagliptin and Heart Failure in the SAVOR-TIMI 53 Trial: Reflections on the Bradford Hill Criteria

Revista española de cardiología (English ed.), 2017-12, Vol.70 (12), p.1143-1144

2017

Volltextzugriff (PDF)

Effect of L-ornithine L-aspartate granules in treating chronic liver disease in patients with high-level serum gamma-glutamyltransferase

Zhonghua gan zang bing za zhi, 2014-07, Vol.22 (7), p.525

2014

Volltextzugriff (PDF)

Aspartate-ornithine granules in the treatment of nonalcoholic steatohepatitis: a multiple-dose parallel controlled clinical trial

Zhonghua gan zang bing za zhi, 2013-07, Vol.21 (7), p.528

2013

Volltextzugriff (PDF)

Saxagliptin efficacy

Diabetes, obesity & metabolism, 2010-08, Vol.12 (8), p.734-734

Valiquette, G.

2010

Volltextzugriff (PDF)

Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

IDrugs : the investigational drugs journal, 2008-12, Vol.11 (12), p.906

Gallwitz, Baptist

2008

Volltextzugriff (PDF)

Ornithine aspartate and naloxone combined therapy for hepatic encephalopathy affects cognitive function, prognosis, and neuropeptide levels

Zhonghua gan zang bing za zhi, 2013-05, Vol.21 (5), p.385

2013

Volltextzugriff (PDF)

Alanyl-glutamine dipeptide inhibits hepatic ischemia-reperfusion injury in rats

World journal of gastroenterology : WJG, 2006-03, Vol.12 (9), p.1373

2006

Volltextzugriff (PDF)

Study on L-Ornithine-L-Aspartate in the treatment of acute-on-chronic liver failure

Zhonghua gan zang bing za zhi, 2011-01, Vol.19 (1), p.63

2011

Volltextzugriff (PDF)

Role of cathepsin B-mediated apoptosis in fulminant hepatic failure in mice

World journal of gastroenterology : WJG, 2009-03, Vol.15 (10), p.1231-1236

2009

Volltextzugriff (PDF)

Confocal Raman Spectral Imaging Study of DAPT, a γ-secretase Inhibitor, Induced Physiological and Biochemical Reponses in Osteosarcoma Cells

International journal of medical sciences, 2020-01, Vol.17 (5), p.577-590

2020

Volltextzugriff (PDF)

Effects of matrix metalloproteinases inhibitor GM6001 on choroidal neovascularization

Chung-hua yen k'o tsa chih, 2012-08, Vol.48 (8), p.744

2012

Volltextzugriff (PDF)

No heart risk--or benefit--from diabetes drug Onglyza

Harvard heart letter, 2013-12, Vol.24 (4), p.8

2013

Volltextzugriff (PDF)

PSMA-targeted radioligand therapy in prostate cancer

Urologe. Ausgabe A, 2017-01, Vol.56 (1), p.32

2017

Volltextzugriff (PDF)

A potent and selective S1P(1) antagonist with efficacy in experimental autoimmune encephalomyelitis

Chemistry & biology, 2012-09, Vol.19 (9), p.1142-1151

2012

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCurrent Opinion In Investigational Drugs

SpracheUkrainisch

Nur zeigenGeprüft (Peer-Review)

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(46)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Dipeptides - Therapeutic Use
(111)
Humans
(96)
Science & Technology
(63)
Life Sciences & Biomedicine
(61)
Animals
(58)
Male
(57)
Dipeptides - Pharmacology
(36)
Female
(35)
Middle Aged
(24)
Rats
(24)
Adamantane - Analogs & Derivatives
(23)
Adult
(23)
Diabetes Mellitus, Type 2 - Drug Therapy
(23)
Mice
(20)
Treatment Outcome
(19)
Adamantane - Therapeutic Use
(18)
Dipeptides - Administration & Dosage
(17)
Dipeptidyl-Peptidase Iv Inhibitors - Therapeutic Use
(17)
Pharmacology & Pharmacy
(17)
Dipeptides - Adverse Effects
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial

Efficacy of birinapant in combination with carboplatin in targeting platinum‑resistant epithelial ovarian cancers

Durability of glycaemic control with dapagliflozin, an SGLT2 inhibitor, compared with saxagliptin, a DPP4 inhibitor, in patients with inadequately controlled type 2 diabetes

Prostate-specific membrane antigen-targeted endoradiotherapy in metastatic prostate cancer

Dipeptidyl peptidase-4 inhibitors: pharmacokinetics, efficacy, tolerability and safety in renal impairment

Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin

Effect of VX‑765 on the transcriptome profile of mice spinal cords with acute injury

The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphoma

Inhibition of ileal bile acid transporter: An emerging therapeutic strategy for chronic idiopathic constipation

Baseline differences in the SAVOR trial

Saxagliptin and sitagliptin in adult patients with type 2 diabetes: a systematic review and meta-analysis

Saxagliptin and Heart Failure in the SAVOR-TIMI 53 Trial: Reflections on the Bradford Hill Criteria

Effect of L-ornithine L-aspartate granules in treating chronic liver disease in patients with high-level serum gamma-glutamyltransferase

Aspartate-ornithine granules in the treatment of nonalcoholic steatohepatitis: a multiple-dose parallel controlled clinical trial

Saxagliptin efficacy

Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

Ornithine aspartate and naloxone combined therapy for hepatic encephalopathy affects cognitive function, prognosis, and neuropeptide levels

Alanyl-glutamine dipeptide inhibits hepatic ischemia-reperfusion injury in rats

Study on L-Ornithine-L-Aspartate in the treatment of acute-on-chronic liver failure

Role of cathepsin B-mediated apoptosis in fulminant hepatic failure in mice

Confocal Raman Spectral Imaging Study of DAPT, a γ-secretase Inhibitor, Induced Physiological and Biochemical Reponses in Osteosarcoma Cells

Effects of matrix metalloproteinases inhibitor GM6001 on choroidal neovascularization

No heart risk--or benefit--from diabetes drug Onglyza

PSMA-targeted radioligand therapy in prostate cancer

A potent and selective S1P(1) antagonist with efficacy in experimental autoimmune encephalomyelitis

Aktive Filter

Suchergebnisse filtern